Tag: Chymopapain

According to the National Institutes of Health, papain is a proteolytic enzyme extracted from the raw fruit of the papaya plant, while chymopapain is another related enzyme from the same source. This guide delves into **what is papain and chymopapain**, exploring their distinct uses, historical medical applications, and associated safety risks.

Anaphylaxis, a severe allergic reaction, occurred in up to 1% of patients treated with chymopapain, contributing to a complex debate about its safety. This article explores the full story of why was chymopapain discontinued despite its effectiveness for many.

First isolated in 1941 from the crude latex of the *Carica papaya* fruit, **what is chymopapain made of** is a natural proteolytic enzyme, historically known for its use in a procedure called chemonucleolysis.

An estimated 80% of people will experience back pain at some point, with some cases resulting from herniated discs. For a time, the drug chymopapain was used for a procedure called chemonucleolysis to address this issue, but its use was ultimately discontinued due to significant risks.